分组1 - ACNB Corporation announced a quarterly cash dividend of $0.38 per share, reflecting an 18.7% increase from the previous dividend of $0.32 per share [1] - The dividend is payable on March 13, 2026, to shareholders of record as of February 27, 2026 [1] - ACNB Corporation is a financial holding company with total assets of $3.23 billion, operating through ACNB Bank and ACNB Insurance Services, Inc. [2] 分组2 - ACNB Bank, founded in 1857, provides banking and wealth management services through a network of 33 community banking offices [2] - ACNB Insurance Services, Inc. is a full-service insurance agency licensed in 46 states, offering a wide range of insurance products [2]

Core Insights - TIFIN Give has partnered with SEI to provide a white-labeled donor-advised fund (DAF) solution for SEI's bank and wealth clients, enhancing innovation and growth in the industry [1][2] Group 1: Partnership Details - The collaboration allows SEI to offer a branded charitable giving experience directly to clients, combining donor experience with administrative and investment flexibility [2] - TIFIN Give addresses the gap in modern DAF offerings for banks and trust organizations, enabling them to retain charitable assets and deepen client relationships [3] Group 2: Strategic Importance - Charitable giving is increasingly recognized as a vital part of holistic wealth planning, with banks needing to retain this service in-house to avoid losing clients to larger providers [4] - The partnership positions philanthropy as a strategic growth lever for SEI's clients, enhancing asset retention and client loyalty [5] Group 3: Platform Features - The TIFIN Give platform offers a fully digital experience that simplifies administration for banks while providing transparency and flexibility for donors [4] - The solution supports branded donor-advised funds and streamlined workflows, aimed at reducing operational friction and improving client experience [4] Group 4: Company Background - TIFIN Give is part of TIFIN, which focuses on applying AI in financial services, particularly in wealth management and philanthropy [6][7] - SEI is a leading provider of financial technology and asset management services, managing approximately $1.9 trillion in assets as of December 31, 2025 [8]

Group 1 - Premium Income Corporation has completed a treasury offering of 2,633,000 preferred shares, generating gross proceeds of $42,654,600, with shares priced at $16.20 each [1] - The preferred shares will trade on the Toronto Stock Exchange under the symbol PIC.PR.A [1] - The preferred shares provide fixed cumulative preferential monthly cash distributions of $0.10625, equating to $1.275 annually, representing a yield of 8.50% based on the original issue price of $15.00 [3] Group 2 - The Fund primarily invests in common shares of major Canadian banks, including Bank of Montreal, The Bank of Nova Scotia, Canadian Imperial Bank of Commerce, National Bank of Canada, Royal Bank of Canada, and The Toronto-Dominion Bank [2] - To enhance returns beyond dividend income, the Fund selectively writes covered call and put options on some or all common shares in its portfolio [2] - Mulvihill Capital Management Inc. serves as the manager and investment manager of the Fund [2]

Core Insights - Algorhythm Holdings, Inc. will showcase its APEX AI SaaS solution at the Link 2026: The Retail Supply Chain Conference, a premier event for retail logistics in the US [1][2] Company Overview - Algorhythm Holdings is a leading AI technology company focused on the development of SemiCab, which addresses supply chain challenges for major retailers and transportation providers globally [5] - SemiCab's AI-enabled Collaborative Transportation Platform optimizes logistics by predicting and managing millions of loads and hundreds of thousands of trucks [5] Industry Context - The U.S. full-truckload market is valued at over $450 billion annually for 2025 and is projected to grow to $535 billion by 2030 [4] - An estimated $150 billion was lost to empty miles in 2025, highlighting inefficiencies in the logistics sector [4] Product Features - SemiCab Apex is designed to integrate seamlessly with existing transportation management systems (TMS) and enhance logistics operations for 3PLs and enterprise shippers [3][7] - The platform allows for the creation of multi-party freight networks, reducing empty miles and unlocking shared efficiencies [7] - Predictive analytics and benchmarking capabilities are included to identify cost savings and improve yield per lane [7]

Core Viewpoint - Longeveron Inc. has received a patent from the Japan Patent Office for potency assay methods related to human mesenchymal stem cells, enhancing its intellectual property portfolio and supporting its clinical programs in regenerative medicine [2][3][4]. Company Overview - Longeveron Inc. is a clinical stage biotechnology company focused on developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions [2][6]. - The company's lead product, laromestrocel (Lomecel-B™), is derived from mesenchymal stem cells (MSCs) isolated from the bone marrow of young healthy adult donors [5][6]. Patent Details - The Japan Patent No. 2022-563984, titled "Potency Assay," grants Longeveron patent rights in Japan until April 20, 2041, contingent on the payment of annuity fees [3]. - This patent covers methods for assessing MSCs derived from various sources, including bone marrow, adipose tissue, and induced pluripotent stem cells (IPSCs) [8]. Clinical Trials and Development - Longeveron has conducted clinical trials for laromestrocel in Alzheimer's disease, aging-related frailty, and hypoplastic left heart syndrome (HLHS), with positive initial results reported [4][8]. - The company is currently conducting a pivotal Phase 2b clinical trial for laromestrocel in HLHS, with results expected in the third quarter of 2026, which may lead to a Biologics License Application (BLA) with the U.S. FDA [4][9]. Regulatory Designations - The HLHS program has received multiple FDA designations, including Orphan Drug, Fast Track, and Rare Pediatric Disease designations, while the Alzheimer's disease program has received Regenerative Medicine Advanced Therapy (RMAT) and Fast Track designations [9].

FDA assigns Prescription Drug User Fee Act (PDUFA) target date of June 29, 2026Ended 2025 with unaudited cash position of $41.3M with expected runway into 2027 LOS ALTOS, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmission of its New Drug Application (NDA) ...

Wix Harmony The new way to create Wix Harmony The ad captures a creative journey with Wix Harmony that moves naturally from inspiration to execution NEW YORK – Wix.com Ltd. (Nasdaq: WIX), a leading global platform for creating, managing and growing a complete digital presence, today unveiled the creative behind its Super Bowl LX commercial, following the launch of Wix Harmony, its new flagship web creation platform. At the heart of the campaign is Wix Harmony’s hybrid creation experience, whic ...

SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation and energy security, has been granted a new patent by the European Patent Office. The patent covers Beam Global’s Phase Change Composite (PCC™) material for Lithium-ion batteries and is titled Smart Phase Change Composite for Passive Thermal Management.The newly allowed European patent claims expand upon Beam Global’s U. ...

Core Viewpoint - Quantum Gyro has made significant advancements in developing a quantum-based gyroscope that promises unjammable, satellite-free navigation solutions, potentially transforming precision navigation in environments where GPS is unavailable [2][4]. Technology Development - Quantum Gyro has achieved performance improvements in gyroscope technology that are several orders of magnitude better than existing systems, indicating a transformative leap in navigation capabilities [2]. - Key benefits of the new technology include unjammable, self-contained navigation, order-of-magnitude drift reduction allowing for accurate navigation for extended periods, software-based scalability for various platforms, and resilience in extreme conditions [2][3]. Market Potential - The global quantum compass navigation market is projected to grow at a robust CAGR of 29.4% from 2025 to 2033, reaching an estimated value of $3.64 billion by 2033, reflecting increasing adoption of next-generation navigation technologies across multiple industries [5]. Acquisition Details - Viewbix has signed a definitive agreement to acquire up to 100% of Quantum X Labs, which includes a growing patent portfolio related to quantum error correction. The acquisition is expected to close within 90 days of the agreement date, pending due diligence and regulatory approvals [6].

Core Insights - Cannibble Food-Tech Ltd. is navigating a challenging environment due to geopolitical conditions in Israel and capital-market constraints, which have impacted its ability to raise capital and advance initiatives [2] - The company has secured additional funding and is now advancing selected strategic initiatives while maintaining its core food-technology business [3] New Division: Robotics and AI - Cannibble has established a Robotics and Artificial Intelligence Division aimed at exploring automation and service robotics opportunities within the food service and hospitality sectors [4] - A collaboration with AIBotics Inc. has been initiated to evaluate the deployment of AI-powered service robots in food service, hospitality, and security applications, starting in Israel and potentially expanding internationally [5] - An initial shipment of service robots from KEENON Robotics has arrived in Israel, awaiting customs clearance to support pilot programs and market assessments [6] Shareholders' Meeting Update - A recent shareholders' meeting resulted in the approval of a resolution to change the company's name, with the new name to be announced soon [8] - Shareholders also approved the continued terms of office for existing directors and reappointed Ziv Haft Chartered Professional Accountants as the auditor for another term [9] Future Outlook - Cannibble plans to continue evaluating strategic initiatives with a focus on disciplined capital allocation, operational execution, and regulatory compliance [10] - The company emphasizes transparent communication with shareholders and aims to advance initiatives that align with its long-term strategy [10]